Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10764136 | Biochemical and Biophysical Research Communications | 2011 | 6 Pages |
Abstract
⺠Epigallocatechin-3-gallate (EGCG) is an ATP-competitive inhibitor of PI3K and mTOR with Ki values around 300 nM. ⺠EGCG inhibits cell proliferation and AKT phosphorylation at Ser473 in MDA-MB-231and A549 cells. ⺠Molecular docking studies show that EGCG binds well to the PI3K kinase domain active site. ⺠These results suggest another important molecular mechanism for the anticancer activities of EGCG.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Glenn S. Van Aller, Jeff D. Carson, Wei Tang, Hao Peng, Lin Zhao, Robert A. Copeland, Peter J. Tummino, Lusong Luo,